References
- Barr AM, Panenka WJ, MacEwan GW, Thornton AE, Lang DJ, Honer WG, Lecomte T. The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci. 2006;31:301–13.
- Seth P, Scholl L, Rudd RA, Bacon S. Overdose deaths involving opioids, cocaine, and psychostimulants—United States, 2015–2016. MMWR Morb Mortal Wkly Rep. 2018;67:349–58. doi: https://doi.org/10.15585/mmwr.mm6712a1.
- Kariisa M, Scholl L, Wilson N, Seth P, Hoots B. Drug overdose deaths involving cocaine and psychostimulants with abuse potential - United States, 2003-2017. MMWR Morb Mortal Wkly Rep. 2019;68:388–95. doi: https://doi.org/10.15585/mmwr.mm6817a3.
- Hedegaard H, Miniño AM, Warner M Drug overdose deaths in the United States, 1999–2018. NCHS Data Brief, no 356. Hyattsville, MD; 2020 [accessed 2020 May 22]. https://stacks.cdc.gov/view/cdc/84647.
- Ellis MS, Kasper ZA, Cicero TJ. Twin epidemics: the surging rise of methamphetamine use in chronic opioid users. Drug Alcohol Depend. 2018;193:14–20. doi: https://doi.org/10.1016/j.drugalcdep.2018.08.029.
- The Lancet. Opioids and methamphetamine: a tale of two crises. Lancet. 2018;391:713. doi:https://doi.org/10.1016/S0140-6736(18)30329-2.
- Palmer A, Scott N, Dietze P, Higgs P. Motivations for crystal methamphetamine-opioid co-injection/co-use amongst community-recruited people who inject drugs: a qualitative study. Harm Reduct J. 2020;17:1–6. doi: https://doi.org/10.1186/s12954-020-00360-9.
- O’Donnell J, Gladden RM, Mattson CL, Hunter CT, Davis NL. Vital signs: characteristics of drug overdose deaths involving opioids and stimulants—24 states and the District of Columbia, January–June 2019. MMWR Morb Mortal Wkly Rep. 2020;69:1189–97. doi: https://doi.org/10.15585/mmwr.mm6935a1.
- Dai Z, Abate MA, Smith GS, Kraner JC, Mock AR. Fentanyl and fentanyl-analog involvement in drug-related deaths. Drug Alcohol Depend. 2019;196:1–8. doi: https://doi.org/10.1016/j.drugalcdep.2018.12.004.
- Farrell M, Martin NK, Stockings E, Bórquez A, Cepeda JA, Degenhardt L, Ali R, Tran LH, Rehm J, Torrens M, et al. Responding to global stimulant use: challenges and opportunities. Lancet. 2019;394:1652–67.
- Hedegaard H, Bastian BA, Trinidad JP, Spencer M, Warner M. Drugs most frequently involved in drug overdose deaths: United States, 2011-2016. Natl Vital Stat Rep. 2018;67:1–14. https://www.cdc.gov/nchs/data/nvsr/nvsr67/nvsr67_09-508.pdf .
- Wilson N, Kariisa M, Seth P, Smith H, Davis NL. Drug and opioid-involved overdose deaths—United States, 2017–2018. MMWR Morb Mortal Wkly Rep. 2020;69:290–97. doi: https://doi.org/10.15585/mmwr.mm6911a4.
- Centers for Disease Control and Prevention, National Center for Health Statistics. NCHS urban-rural classification scheme for counties. Hyattsville, MD; 2017 [accessed 2020 Jul 1]. https://www.cdc.gov/nchs/data_access/urban_rural.htm#:~:text=National%20Center%20for%20Health%20Statistics,counties%20and%20county%2Dequivalent%20entities .
- Lumley T, Scott A. Fitting regression models to survey data. Stat Sci. 2017;32:265–78. doi:https://doi.org/10.1214/16-STS605.
- Gladden RM, O’Donnell J, Mattson CL, Set P. Changes in opioid-involved overdose deaths by opioid type and presence of benzodiazepines, cocaine, and methamphetamine—25 states, July–December 2017 to January–June 2018. MMWR Morb Mortal Wkly Rep. 2018;68:737–44. doi: https://doi.org/10.15585/mmwr.mm6834a2.
- Hedegaard H, Miniño AM, Warner M. Co-involvement of opioids in drug overdose deaths involving cocaine and psychostimulants. NCHS Data Brief, no 406. Hyattsville, MD: National Center for Health Statistics. 2021. doi: https://doi.org/10.15620/cdc:103966
- LaRue L, Twillman RK, Dawson E, Whitley P, Frasco MA, Huskey A, Guevara MG. Rate of fentanyl positivity among urine drug test results positive for cocaine or methamphetamine. JAMA Netw Open. 2019;2:e192851. doi: https://doi.org/10.1001/jamanetworkopen.2019.2851.
- Twillman RK, Dawson E, LaRue L, Guevara MG, Whitley P, Huskey A. Evaluation of trends of near-real-time urine drug test results for methamphetamine, cocaine, heroin, and fentanyl. JAMA Netw Open. 2020;3:e1918514. doi: https://doi.org/10.1001/jamanetworkopen.2019.18514.
- Zhao SX, Kwong C, Swaminathan A, Gohil A, Crawford M. Clinical characteristics and outcome of methamphetamine-associated pulmonary arterial hypertension and dilated cardiomyopathy. JACC Heart Fail. 2018;6:209–18. doi: https://doi.org/10.1016/j.jchf.2017.10.006.
- Volkow ND. Collision of the COVID-19 and addiction epidemics. Ann Intern Med. 2020;173:61–62. doi: https://doi.org/10.7326/M20-1212.
- Jones CM, Underwood N, Compton W. Increases in methamphetamine use among heroin treatment admissions in the United States, 2008-2017. Addiction. 2019;115:347–53. doi: https://doi.org/10.2105/AJPH.2019.305527.
- Al-Tayyib A, Koester S, Langegger S, Raville L. Heroin and methamphetamine injection: an emerging substance use pattern. Subst Use Misuse. 2017;52:1051–58. doi: https://doi.org/10.1080/10826084.2016.1271432.
- Strickland JC, Havens JR, Stoops WW. A nationally representative analysis of “twin epidemics”: rising rates of methamphetamine use among persons who use opioids. Drug Alcohol Depend. 2019;204:107592. doi: https://doi.org/10.1016/j.drugalcdep.2019.107592.
- Mars SG, Rosenblum D, Ciccarone D. Illicit fentanyls in the opioid street market: desired or imposed? Addiction. 2019;114:774–80. doi: https://doi.org/10.1111/add.14474.
- Jones CM, Compton WM, Mustaquim D. Patterns and characteristics of methamphetamine use among adults—United States, 2015–2018. MMWR Morb Mortal Wkly Rep. 2020;69:317–23. doi: https://doi.org/10.15585/mmwr.mm6912a1.
- Logan BK, Fligner CL, Haddix T. Cause and manner of death in fatalities involving methamphetamine. J Forensic Sci. 1998;43:28–34. doi: https://doi.org/10.1520/JFS16085J.
- Karch SB, Stephens BG, Ho CH. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles. J Forensic Sci. 1999;44:359–68. doi: https://doi.org/10.1520/JFS14464J.
- Darke S, Kaye S, Duflou J. Rates, characteristics and circumstances of methamphetamine‐related death in Australia: a national 7‐year study. Addiction. 2017;112:2191–201. doi:https://doi.org/10.1111/add.13897.
- Rockett IR, Caine ED, Connery HS, D’Onofrio G, Gunnell DJ, Miller TR, Jia H. Discerning suicide in drug intoxication deaths: paucity and primacy of suicide notes and psychiatric history. PLoS One. 2018;13:e0190200. doi: https://doi.org/10.1371/journal.pone.0190200.
- Thomas IC, Nishimura M, Ma J, Dickson SD, Alshawabkeh L, Adler E, Maisel A, Criqui MH, Greenberg B. Clinical characteristics and outcomes of patients with heart failure and methamphetamine abuse. J Card Fail. 2020;26:202–09. doi: https://doi.org/10.1016/j.cardfail.2019.10.002.
- Krasnova IN, Cadet JL. Methamphetamine toxicity and messengers of death. Brain Res Rev. 2009;60:379–407. doi: https://doi.org/10.1016/j.brainresrev.2009.03.002.
- Tsui JI, Mayfield J, Speaker EC, Yakup S, Ries R, Funai H, Leroux BG, Merrill JO. Association between methamphetamine use and retention among patients with opioid use disorders treated with buprenorphine. J Subst Abuse Treat. 2020;109:80–85. doi: https://doi.org/10.1016/j.jsat.2019.10.005.
- Timko C, Han X, Woodhead E, Shelley A, Cucciare MA. Polysubstance use by stimulant users: health outcomes over three years. J Stud Alcohol Drugs. 2018;79:799–807. doi: https://doi.org/10.15288/jsad.2018.79.799.
- Jones CM, Olsen EO, O’Donnell J, Mustaquim D. Resurgent methamphetamine use at treatment admission in the United States, 2008–2017. Am J Public Health. 2020;110:509–16. doi: https://doi.org/10.2105/AJPH.2019.305527.
- Palamar JJ, Han BH, Keyes KM. Trends in characteristics of individuals who use methamphetamine in the United States, 2015-2018. Drug Alcohol Depend. 2020;213:108089. doi: https://doi.org/10.1016/j.drugalcdep.2020.108089.
- Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry. 2021;34:344–50. doi: https://doi.org/10.1097/YCO.0000000000000717.